Fig 1.
The efficacy of Miransertib (ARQ092) as compared to miltefosine on promastigote forms of Leishmania amazonensis (A) and Leishmania donovani (B) was measured in MTT assays after 24 h treatment of each drug at increasing concentrations. The proportion of surviving parasites was analyzed by GraphPad prism and the EC50 was calculated from those plots. The data was compiled from at least 3 independent experiments.
